US National TOP Registry
Condition(s) studied
Investigational drug(s) / intervention(s)
OCS Lung: The TransMedics Organ Care System (OCS) Lung is an FDA approved portable extracorporeal lung perfusion and monitoring system.
Study summary
The objective of this Registry is to collect short and long-term post-transplant clinical outcome data of all donor lungs preserved and assessed on the OCS Lung System and to document the performance of the OCS device in the real-world setting after FDA approval in the US.
Eligibility
Primary outcome measure(s)
- One-year patient and graft survival — 1-year post-transplant
Recipients' one-year patient and graft survival rates
Trial sites (7)
| Facility | City | Region | Status |
|---|---|---|---|
| St. Joseph's Hospital & Medical Center | Phoenix | Arizona | Recruiting |
| Stanford University School of Medicine | Stanford | California | Recruiting |
| University of Minnesota | Minneapolis | Minnesota | Recruiting |
| Duke University | Durham | North Carolina | Recruiting |
| Baylor Scott & White Research Institute | Dallas | Texas | Recruiting |
| Baylor College of Medicine | Houston | Texas | Recruiting |
| Medical College of Wisconsin | Milwaukee | Wisconsin | Recruiting |
More TransMedics trials in the USA
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06513091 on ClinicalTrials.gov ↗ ← All trials in the USA